Lab Profiles

A key component of the CNTM research is developing preclinical disease models, which allow direct translation to the patient applications. These range from in vivo models of complex disease to next generation human organoid 3D models.   With these capabilities, the Centre and its researchers are involved in numerous projects with health and clinical partners, such as the NHS and Cancer Research UK, to bring these new technologies to the medical frontline.

CORE LABS

Studies how nanomaterials may trigger inflammation or be used to modulate inflammation and control disease.

Explores interactions of nanomaterials with cells focusing on deciphering their interactions with plasma membrane, cellular uptake pathways and intracellular trafficking & subcellular localisation.

Aims to generate fundamental knowledge about the interaction of nanomaterials with blood components, with the ultimate goal to unveil novel biomarker panels for disease detection and monitoring, and untangle underlying biological processes and molecular pathways.

Aims to exploit the properties of nanoparticles and their interactions with cells and tissues for the development of safe and effective medicines, using clinically-relevant disease models.

AFFILIATE LABS

Aims to exploit the properties of nanoparticles and their interactions with cells and tissues for the development of safe and effective medicines, using clinically-relevant disease models.

Dedicated to the development of nanomaterials, advanced materials and devices for therapeutic and diagnostics applications. Clinical translation of nanotechnology and nanoscience is the main expertise and driver.

CORE LABS

AFFILIATE LABS

PART OF